Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its ...
Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...
The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback